INTRODUCCIÓN L os primeros registros en la literatura sobre el linfoma anaplásico de células gigantes se tienen en la década de los noventa. En la revista de nuestra especialidad, el primer caso aparece reportado en el año de 1997. 1,2 Desde entonces hemos visto un incremento en la incidencia, junto con un mayor reporte y conocimiento de esta patología. En 2016, revisamos la literatura y encontramos 80 casos. 3 De acuerdo con el Global Task Force contamos actualmente con más de 600 casos; posiblemente esta cifra aumente, por lo que debemos tener mayor conocimiento del problema. Esta patología ha causado un alto impacto en las autoridades sanitarias, sociedades médicas, medios de comunicación y pacientes. Además, la información que se genera con frecuencia es controvertida y no dx.doi.org/10.35366/CP191H Manejo del seroma crónico en pacientes con implantes de mama en relación con el diagnóstico de linfoma anaplásico de células gigantes Management of chronic seroma in patients with breast implants in relation to the diagnosis of anaplastic lymphoma of giant cells
Soft tissue sarcomas are malignant tumors derived from the mesoderm, the most frequent age of presentation is between the 5 th and 7 th decade of life, mostly in males, more frequent location in the extremities, leaving only 1% of presentation in skin hairy, and this is a new concept of treating big sarcomas. We present the case of a 45-year-old male with a diagnosis of soft tissue sarcoma on the frontal, parietal, and right occipital surface of approximately 35x28x25 cm, without involvement of adjacent organs, without adjuvant therapy. Performing an oncological resection, exposing the periosteum, performing fenetrations of the external table, covering the Dermal Matrix -Integra®, using a new concept to treat this large defects, after 3 weeks with complete neodermis, we cover it with a Partial Thickness Graft, achieving 100% integration. and proper follow-up. Sarcomas are an uncommon and heterogeneous group of neoplasms of mesenchymal origin. Standard use of Integra reconstruction requires two stages: Integra forms a neo dermis through ingrowth of host vessels, followed by application of a thin split-thickness skin graft at a later date <30 days, using this new concepts of treating large defects with no flap. Sarcomas are highly aggressive and have very varied symptoms depending on the tumor stage at the time of diagnosis. Timely and improved a new concept of treatment such as an Integra® dermal regenerator, not using a flap, shows adequate integration in the patient and survival.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.